Free delivery over $100 Learn more

30 days return period Learn more
SKU: 0164ATC

DMS 273 Human Pleural Fluid Small Cell Lung Cancer Specialized Cells

Tumor Cell Lines > Lung Cancer Cell Lines

Product Type: Human Lung Cancer Cell Lines

Species: Human

Cell Type: Other / Specialized Cells

Source Organ: Lung

$1,249.00
Size

Care information

Display general product information or specific product information using metafields.

Delivery and Shipping

Add some general information about your delivery and shipping policies.

Cell Name: DMS 273

Human lung, small cell carcinoma. DMS 273 was initiated in 1978 from the pleural fluid specimen from a 50 year old female patient with small cell carcinoma of the lung. The patient was in relapse after chemotherapy and radiotherapy.

  • Description
    DMS 273 is a human small cell lung carcinoma cell line derived in 1978 from the pleural fluid of a 50-year-old Caucasian female patient who had relapsed following chemotherapy and radiotherapy. Originating from small cell carcinoma of the lung, the cells exhibit an adherent morphology with intercellular processes and retain features of small cell carcinoma. DMS 273 cells are cultured in RPMI-1640 medium supplemented with 10% fetal bovine serum at 37°C and 5% CO₂. They express mRNA and proteins associated with the retinoblastoma gene and harbor a p53 gene mutation (G245C). Additionally, they express hepatocyte growth factor (HGF) and its receptor, receptor tyrosine kinase MET (RTK-MET). These cells are tumorigenic when implanted in nude mice.
  • Product Name
    DMS 273
  • Product Type
    Human Lung Cancer Cell Lines
  • Species
    Human
  • Source Organ
    Pleural Fluid
  • Disease
    Small Cell Lung Cancer
  • Product Type
    Human Lung Cancer Cell Lines
  • Growth Conditions
    37 °C, 5% CO2
  • Application
    DMS-273 is a valuable cell line for studying small-cell lung cancer (SCLC), an aggressive cancer known for its high metastatic potential. Transplanting DMS-273 into the lungs of nude mice creates a metastasis model and facilitates the testing of drugs or inhibitors. For instance, DMS-273 exhibits amplification of the SETDB1 gene, resulting in the overexpression of SETDB1 protein, enhancing cell invasion in lung carcinoma. This finding provides insights into the potential of SETDB1 inhibitors as new therapies. Similarly, in DMS-273, inhibitors or siRNA targeting signaling pathways associated with cancer progression and invasion can be tested to impede the progression of SCLC.
  • Size/Quantity
    1 vial
  • Recommended Medium And Supplement

    Waymouth’s MB 752/1 + 2mM Glutamine + 10% FBS
  • Shipping Conditions
    Dry Ice
  • Storage
    Liquid Nitrogen
  • Biosafety Level
    1

Payment & Security

Payment methods

    Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.

    • Visit our support center

      Expert help & advice

    • Check your order status

      Updates & tracking

    • Returns & exchanges

      All you need to know

    • Price-match guarantee

      Our promise to you